ANAB Financials
AnaptysBio Inc - Financial statements & key metrics
Stock Price
$56.13
Market Cap
$1.62B
P/E Ratio
-11.0
EPS
$-5.12
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$91.28M
Gross Profit
-
Operating Income
-
Net Income
$-145.23M
EPS (Diluted)
$-5.12
Balance Sheet Highlights
Total Assets
$483.83M
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$123.08M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-135.34M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-159.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ANAB revenue?
ANAB's most recent quarterly revenue was $91.28M. Annual revenue can be calculated by summing the four most recent quarters.
Is ANAB profitable?
ANAB reported a loss of $145.23M in the most recent quarter. The net profit margin is -159.1%.
What is ANAB market cap?
ANAB has a market capitalization of $1.62B, making it a small-cap stock.
Does ANAB have debt?
View ANAB's balance sheet for debt information.
What is ANAB cash flow?
Cash flow data is available in the full financial statements.